United States 112th Congress Status: Died 1 D cosponsors

SRES 529 — A resolution recognizing that the occurrence of prostate cancer in African-American men has reached epidemic proportions and urging Federal agencies to address that health crisis by supporting education, awareness outreach, and research specifically focused on how prostate cancer affects African-American men.

Last action — Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5626-5627; text as passed Senate: CR S5626; text of measure as introduced: CR S5493)

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. Died in session

This bill died with 112th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Recognizes: (1) that prostate cancer has created a health crisis for African-American men; and (2) the importance of health coverage and access to care, as well as promoting informed decisionmaking between men and their doctors, taking into consideration the known risks and potential benefits of screening and treatment options for prostate cancer. Urges federal agencies to support: (1) research to address and attempt to end that crisis; (2) efforts relating to education, awareness, and early detection at the grassroots level; and (3) the Office of Minority Health of the Department of Health and Human Services (HHS) in focusing on improving health and health care outcomes for African Americans at an elevated risk. Urges investment by federal agencies in research focusing on the improvement of early detection and treatment, such as the use of: (1) biomarkers to distinguish indolent forms of prostate cancer from lethal forms, and (2) advanced imaging tools.

Bill Text

We don't have the full text on file for this bill yet.

Read SRES 529 on the official United States source →

Action History

  1. Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5626-5627; text as passed Senate: CR S5626; text of measure as introduced: CR S5493)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SRES 529 do?
Recognizes: (1) that prostate cancer has created a health crisis for African-American men; and (2) the importance of health coverage and access to care, as well as promoting informed decisionmaking between men and their doctors, taking into consideration the known risks and potential benefits of screening and treatment options for prostate cancer. Urges federal agencies to support: (1) research to address and attempt to end that crisis; (2) efforts relating to education, awareness, and early detection at the grassroots level; and (3) the Office of Minority Health of the Department of Health and Human Services (HHS) in focusing on improving health and health care outcomes for African Americans at an elevated risk. Urges investment by federal agencies in research focusing on the improvement of early detection and treatment, such as the use of: (1) biomarkers to distinguish indolent forms of prostate cancer from lethal forms, and (2) advanced imaging tools.
Who sponsors SRES 529?
SRES 529 is sponsored by John Kerry (Democrat).
What is the current status of SRES 529?
This bill died with 112th Congress. It reached “Passed House” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SRES 529?
Track SRES 529 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SRES 529

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SRES 529

Last checked for changes about 17 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →